Abiopharma

Investor Notice: Robbins LLP Informs Investors of the First Solar, Inc. Class Action Lawsuit

New Five9 Research: AI Adoption in CX Hits 92%, But Consumer Trust Still Depends on Human Support

Thomas Carr Howe Middle School Unveils New Fitness and Strength Training Space Through Partnership with Elevance Health and Impact Fitness Foundation

Statement From the Board of Brera Holdings Plc (“Solmate”)

Swedish Court Further Reschedules Delivery of Judgment in PriceRunner Vs Google Antitrust Case

Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

EShallGo Inc. Announces Pricing of $1.479 Million Registered Direct Offering

Corning Announces Quarterly Dividend

Catalyst Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalyst Pharmaceuticals, Inc. - CPRX

TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)